128 related articles for article (PubMed ID: 34390292)
1. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation.
Li M; Zhong Y; Wang M
Environ Toxicol; 2021 Nov; 36(11):2333-2341. PubMed ID: 34390292
[TBL] [Abstract][Full Text] [Related]
2. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness.
Yuan Y; Zhong W; Ma G; Zhang B; Tian H
Mol Med Rep; 2015 Jun; 11(6):4267-72. PubMed ID: 25607725
[TBL] [Abstract][Full Text] [Related]
4. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract][Full Text] [Related]
5. [Expression of FAT1 in Lung Adenocarcinoma and Its Relationship
with Immune Cell Infiltration].
Ding C; Zhao W; Huang H; Li Y; Zhang Z; Zhang R; Wang Y; Wu D; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):109-117. PubMed ID: 38453442
[TBL] [Abstract][Full Text] [Related]
6. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses the stemness of non-small cell lung cancer cells via promoting the nuclear-cytoplasm translocation of TAZ.
Zheng Y; Yang X; Tan J; Tian R; Shen P; Cai W; Liao H
Environ Toxicol; 2021 Jun; 36(6):1135-1142. PubMed ID: 33539684
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
9. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C
Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Wang X; Yu X; Wei W; Liu Y
Environ Toxicol; 2020 Sep; 35(9):998-1006. PubMed ID: 32401390
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Hsu PC; Jablons DM; Yang CT; You L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
[TBL] [Abstract][Full Text] [Related]
13. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
15. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
17. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
Hu Z; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
[TBL] [Abstract][Full Text] [Related]
19. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
[TBL] [Abstract][Full Text] [Related]
20. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
Wei D; Sun L; Feng W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]